Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Sci Rep ; 11(1): 9523, 2021 05 04.
Article in English | MEDLINE | ID: mdl-33947944

ABSTRACT

Fused in sarcoma/translocated in liposarcoma (FUS/TLS) is a multitasking RNA/DNA binding protein. FUS aggregation is implicated in various neurodegenerative diseases. RNA was suggested to modulate phase transition of FUS. Here, we found that FUS transforms into the amorphous aggregation state as an instant response to the shear stress caused by usual pipetting even at a low FUS concentration, 100 nM. It was revealed that non-coding RNA can suppress the transformation of FUS into aggregates. The suppressive effect of RNA on FUS aggregation is sequence-dependent. These results suggested that the non-coding RNA could be a prospective suppressor of FUS aggregation caused by mechanistic stress in cells. Our finding might pave the way for more research on the role of RNAs as aggregation inhibitors, which could facilitate the development of therapies for neurodegenerative diseases.


Subject(s)
RNA, Untranslated/genetics , RNA-Binding Protein FUS/genetics , DNA-Binding Proteins/genetics , Protein Aggregates/genetics , RNA-Binding Proteins/genetics , Shear Strength/physiology
2.
Chem Commun (Camb) ; 56(64): 9134-9137, 2020 Aug 11.
Article in English | MEDLINE | ID: mdl-32643734

ABSTRACT

High-speed AFM revealed the conformational change of fused in sarcoma (FUS) from a compact to an extended structure upon binding of non-coding RNA, which is supposed to allow FUS to bind to CBP/p300 for transcriptional interference. Thus, a mechanistic insight into transcription regulation by FUS and non-coding RNA is provided.


Subject(s)
RNA, Untranslated/metabolism , RNA-Binding Protein FUS/metabolism , Green Fluorescent Proteins/chemistry , Intrinsically Disordered Proteins/chemistry , Intrinsically Disordered Proteins/metabolism , Maltose-Binding Proteins/chemistry , Microscopy, Atomic Force , Promoter Regions, Genetic , Protein Binding , Protein Conformation , RNA-Binding Protein FUS/chemistry
3.
Sci Rep ; 10(1): 2629, 2020 02 14.
Article in English | MEDLINE | ID: mdl-32060318

ABSTRACT

Translocated in liposarcoma (TLS)/fused in sarcoma (FUS) is a multitasking DNA/RNA binding protein implicated in cancer and neurodegenerative diseases. Upon DNA damage, TLS is recruited to the upstream region of the cyclin D1 gene (CCND1) through binding to the promotor associated non-coding RNA (pncRNA) that is transcribed from and tethered at the upstream region. Binding to pncRNA is hypothesized to cause the conformational change of TLS that enables its inhibitive interaction with histone acetyltransferases and resultant repression of CCND1 expression, although no experimental proof has been obtained. Here, the closed-to-open conformational change of TLS on binding pncRNA was implied by fluorescence resonance energy transfer. A small fragment (31 nucleotides) of the full-length pncRNA (602 nucleotides) was shown to be sufficient for the conformational change of TLS. Dissection of pncRNA identified the G-rich RNA sequence that is critical for the conformational change. The length of RNA was also revealed to be critical for the conformational change. Furthermore, it was demonstrated that the conformational change of TLS is caused by another target DNA and RNA, telomeric DNA and telomeric repeat-containing RNA. The conformational change of TLS on binding target RNA/DNA is suggested to be essential for biological functions.


Subject(s)
RNA, Untranslated/metabolism , RNA-Binding Protein FUS/metabolism , Base Sequence , Binding Sites , Fluorescence Resonance Energy Transfer , Humans , Nucleic Acid Conformation , Promoter Regions, Genetic , Protein Binding , Protein Conformation , RNA, Untranslated/chemistry , RNA-Binding Protein FUS/chemistry
4.
Proc Natl Acad Sci U S A ; 110(19): 7784-9, 2013 May 07.
Article in English | MEDLINE | ID: mdl-23610419

ABSTRACT

Somatic hypermutation (SHM) requires not only the expression of activation-induced cytidine deaminase, but also transcription in the target regions. However, how transcription guides activation-induced cytidine deaminase in targeting SHM to the Ig genes is not fully understood. Here, we found that the "facilitates chromatin transcription" (FACT) complex promotes SHM by RNAi screening of transcription elongation factors. Furthermore, FACT and histone H3.3, a hallmark of transcription-coupled histone turnover, are enriched at the V(D)J region, 5' flanking sequence of the Sµ switch region and the light chain Jκ 5 segment region in the Ig loci. The regions with the most abundant deposition of FACT and H3.3 were also the most efficient targets of SHM. These results demonstrate the importance of histone-exchanging dynamics at the chromatin of SHM targets, especially in Ig genes.


Subject(s)
Chromatin/chemistry , DNA-Binding Proteins/metabolism , High Mobility Group Proteins/metabolism , Histones/genetics , Somatic Hypermutation, Immunoglobulin , Transcriptional Elongation Factors/metabolism , Cell Line, Tumor , Chromatin/metabolism , Cinnamates/metabolism , Cytidine Deaminase/genetics , DNA Mutational Analysis , DNA-Binding Proteins/genetics , Genes, Reporter , Genetic Markers , Green Fluorescent Proteins/metabolism , High Mobility Group Proteins/genetics , Humans , Hygromycin B/analogs & derivatives , Hygromycin B/metabolism , Immunoglobulin Class Switching , Immunoglobulins/genetics , RNA Interference , RNA, Small Interfering/metabolism , Sequence Analysis, DNA , Transcription, Genetic , Transcriptional Elongation Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL